{
  "name": "The HRT Index U.S. Menopause HRT Supply Monitor",
  "snapshot_id": "HRTI-HRTS-US-2026-07-31-v1",
  "tracker_verified_at": "2026-07-31",
  "country": "United States",
  "scope": "Prescription estrogen and progestogen products commonly used for menopause and perimenopause",
  "headline_findings": {
    "ashp_current_product_groups": 3,
    "matching_fda_current_product_groups": 0,
    "affected_presentation_entries": 26,
    "source_listed_available_entries": 31
  },
  "source_agreement_taxonomy": [
    "Both",
    "ASHP-only",
    "FDA-only",
    "Neither/local report only"
  ],
  "methodology": {
    "fda_query_terms": [
      "estradiol",
      "estrogen",
      "progesterone",
      "medroxyprogesterone",
      "norethindrone",
      "conjugated estrogens",
      "bazedoxifene",
      "levonorgestrel",
      "testosterone"
    ],
    "presentation_counting_rule": "Count each ASHP affected-products or available-products line item as one presentation entry.",
    "source_age_rule": "Tracker verification date minus the primary source date.",
    "current_status_rule": "Preserve FDA and ASHP status separately; do not infer local inventory or therapeutic interchangeability."
  },
  "fda_extraction_receipt": {
    "retrieved": "2026-07-31",
    "downloaded_file_size_bytes": 535002,
    "rows_parsed": 1636,
    "maximum_update_date": "2026-07-31",
    "sha256": "ac82aa0debc45af080a385a9ae692c1015331bb1a503e182d08a1151dd40ccc8",
    "status_counts": {
      "Current": 1180,
      "To Be Discontinued": 432,
      "Resolved": 24
    },
    "matching_hormone_term_rows": [
      {
        "generic_name": "Progesterone Vaginal Gel",
        "company_name": "AbbVie Inc.",
        "presentation": "Crinone, Vaginal Gel, 4% (NDC 0023-6150-04)",
        "status": "To Be Discontinued",
        "date_of_update": "2026-03-27",
        "included_in_current_shortage_count": false
      }
    ]
  },
  "records": [
    {
      "snapshot_id": "HRTI-HRTS-US-2026-07-31-v1",
      "tracker_verified_at": "2026-07-31",
      "country": "United States",
      "scope": "Prescription estrogen and progestogen products commonly used for menopause and perimenopause",
      "product_group": "Estradiol transdermal system",
      "route": "Transdermal",
      "ashp_status": "Current",
      "fda_current_match": "No",
      "source_agreement": "ASHP-only",
      "affected_presentation_count": 20,
      "source_listed_available_count": 26,
      "ashp_first_posted": "2026-01-30",
      "ashp_source_date": "2026-07-01",
      "source_age_days": 30,
      "resupply_estimate_state": "Mixed: allocation, intermittent weekly releases, back order without an estimate, and available presentations",
      "ashp_source_url": "https://www.ashp.org/drug-shortages/current-shortages/drug-shortage-detail.aspx?id=1206",
      "fda_source_url": "https://www.accessdata.fda.gov/scripts/drugshortages/default.cfm"
    },
    {
      "snapshot_id": "HRTI-HRTS-US-2026-07-31-v1",
      "tracker_verified_at": "2026-07-31",
      "country": "United States",
      "scope": "Prescription estrogen and progestogen products commonly used for menopause and perimenopause",
      "product_group": "Progesterone capsules",
      "route": "Oral",
      "ashp_status": "Current",
      "fda_current_match": "No",
      "source_agreement": "ASHP-only",
      "affected_presentation_count": 3,
      "source_listed_available_count": 3,
      "ashp_first_posted": "2026-05-14",
      "ashp_source_date": "2026-06-30",
      "source_age_days": 31,
      "resupply_estimate_state": "One affected presentation had no estimate; two had an early-July estimate that had passed by verification",
      "ashp_source_url": "https://www.ashp.org/drug-shortages/current-shortages/drug-shortage-detail.aspx?id=1227",
      "fda_source_url": "https://www.accessdata.fda.gov/scripts/drugshortages/default.cfm"
    },
    {
      "snapshot_id": "HRTI-HRTS-US-2026-07-31-v1",
      "tracker_verified_at": "2026-07-31",
      "country": "United States",
      "scope": "Prescription estrogen and progestogen products commonly used for menopause and perimenopause",
      "product_group": "Estradiol vaginal cream",
      "route": "Vaginal",
      "ashp_status": "Current",
      "fda_current_match": "No",
      "source_agreement": "ASHP-only",
      "affected_presentation_count": 3,
      "source_listed_available_count": 2,
      "ashp_first_posted": "2026-06-06",
      "ashp_source_date": "2026-06-06",
      "source_age_days": 55,
      "resupply_estimate_state": "Mylan estimate passed; Teva's late-July estimate reached or passed; Padagis remained on allocation in the source",
      "ashp_source_url": "https://www.ashp.org/drug-shortages/current-shortages/drug-shortage-detail.aspx?id=1229",
      "fda_source_url": "https://www.accessdata.fda.gov/scripts/drugshortages/default.cfm"
    }
  ],
  "limitations": [
    "National status does not show inventory at an individual pharmacy.",
    "Presentation-entry counts are not patient, prescription, package, inventory, or market-share counts.",
    "Source-listed availability does not establish therapeutic interchangeability.",
    "Elapsed manufacturer estimates remain unconfirmed until an authoritative source changes.",
    "Testosterone products are outside this dataset’s declared estrogen-and-progestogen scope."
  ]
}